Alphabet spinoff SandboxAQ has successfully raised over $300 million in its latest funding round, aimed at advancing artificial intelligence applications in various sectors, including drug discovery. This funding round has increased the company's valuation to approximately $5.6 billion, as confirmed by CEO Jack Hidary in an exclusive interview. The investment comes at a time when many companies in the tech sector are facing challenges, highlighting SandboxAQ's strong market position and investor confidence.